MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
3.520
-0.010 (-0.28%)
At close: Sep 5, 2025, 4:00 PM
3.530
+0.010 (0.28%)
After-hours: Sep 5, 2025, 4:00 PM EDT
MDxHealth Market Cap
MDxHealth has a market cap or net worth of $174.73 million as of September 5, 2025. Its market cap has increased by 87.22% in one year.
Market Cap
174.73M
Enterprise Value
225.93M
1-Year Change
87.22%
Ranking
Category
Stock Price
$3.52
Market Cap Chart
Since the IPO on May 12, 2017, MDxHealth's market cap has decreased from $269.23M to $174.73M, a decrease of -35.10%. That is a compound annual growth rate of -5.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 174.73M | 55.90% |
| Dec 31, 2024 | 112.07M | 4.24% |
| Dec 29, 2023 | 107.52M | 659,987.71% |
| Dec 29, 2022 | 16.29K | -99.98% |
| Dec 30, 2020 | 91.60M | 18.07% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| May 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |